Video

Pfizer CentreOne Sterile Injectables Capacity Update October 2025: Fill/Finish

In the fast-moving sterile injectable (SI) space, quality and expertise are essential to safely and successfully delivering breakthrough therapeutics to patients. Backed by Pfizer’s global network, our scientific and manufacturing experts leverage decades of experience and specialized facilities to meet complex fill-finish needs—from oncology medicines and novel vaccines to mAbs—ensuring precision in every dose and helping you navigate regulatory and scientific advancements.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Pfizer CentreOne